I asked Hopper and Dr Bec whether there was any offer,...

I asked Hopper and Dr Bec whether there was any offer, regardless of acceptable or not, but did not get an answer.

It simply amazes me that you might think they are gunna share info with u


Maybe the planned and failed CR in mid 2024 was an offer that got withdrawn or refused, who knows. Now holders can only hope that the ph1 data convince Dr Bec's pharma friends to come up with a funding arrangement. A deal similar to RAD / Lantheus would be desirable despite the sp over there is failing to value that Lantheus practically now funds and manages RAD.

Just more speculation / guesswork

Anyway, if a RAD-style deal is announced I will be jumping back in, until then, watching from the sidelines.

Enjoy the view from the sidelines ..... and yes I agree with you CGM is high risk / high reward play ........ the moment all your requirements come into place ..... it ceases to be such a potential " High Reward " relative to the cost ..... only because the cost will have gone up 5-10 fold I suspect .

Personally I dont mind a bit of a gamble ..... and given the background and whats been conveyed to us so fare ....... a few bucks dropped into CHM at these levels ..... and the possible projected odds on the ticket 30 : 1 looks ok for the "smallest market cap Biotech .....with the Biggest potential gain "


Others my not agree ....thats cool

Different strokes for different folks

Lol